Rosales, Nilda .
HRN: 25-05-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/06/2024
11/13/2024
IV
300 MG
Q6H
INFECTED WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes